ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPPON CHEMIPHAR CO., LTD.
  3. Financials
  4. Pretax margin (%)

NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥7.2B
P/E ratio
40.4x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 20251.4-290.97%
Mar 31, 2024-0.7-487.55%
Mar 31, 20230.2-94.15%
Mar 31, 20223.1+70.39%
Mar 31, 20211.8+90.87%
Mar 31, 20201-78.14%
Mar 31, 20194.4-7.85%
Mar 31, 20184.8-39.87%
Mar 31, 20178-3.50%
Mar 31, 20168.3-9.70%
Mar 31, 20159.2-8.87%
Mar 31, 201410.1-13.54%
Mar 31, 201311.6+19.42%
Mar 31, 20129.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat